Uses of integrin alphavbeta3 antagonists

Details for Australian Patent Application No. 2004207002 (hide)

Owner Medimmune, Inc.

Inventors Wilder, Ronald L.; Mao, Su-Yau

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004207002

PCT Pub. Number WO2004/066956

Priority 60/444,156 30.01.03 US

Filing date 30 January 2004

Wipo publication date 12 August 2004

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/066956 Priority application(s): WO2004/066956

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207003-Anti-integrin alphanubeta3 antibody formulations and uses thereof

2004206998-System and method for identifying tissue using low-coherence interferometry